(Stroke. 1996;27:672-676.)
© 1996 American Heart Association, Inc.
Articles |
From the Kaunas Medical Academy, Institute of Cardiology, Lithuania (D.R., S.D., R.R.), and the National Public Health Institute, Department of Epidemiology and Health Promotion, Helsinki, Finland (J.T., Z.C.).
Correspondence to Dr Daiva Rastenyte, Institute of Cardiology, St Sukileliu 17, LIT-3007 Kaunas, Lithuania.
| Abstract |
|---|
|
|
|---|
Methods We conducted a prospective study with an average follow-up of 17.5 years of 2295 men who had participated in risk factor surveys within the framework of the World Health Organization Kaunas-Rotterdam Intervention Study from 1972 to 1974. Risk factors included in the current analyses were smoking, blood pressure, serum total cholesterol, glucose intolerance, diabetes, and body mass index. Age- and risk factoradjusted relative risks (RR) for death of stroke were determined by use of the Cox proportional hazards model.
Results The strongest risk factors for death from stroke in middle-aged men were systolic blood pressure (RR=1.02; P=.0001), diabetes (RR=4.17; P=.02), and smoking (RR=2.01; P=.004). Serum cholesterol, impaired glucose tolerance, and body mass index were not related to the risk of death from stroke. Twenty-five percent and 19% of stroke deaths were attributed to hypertension and smoking, respectively.
Conclusions Prevention and effective control of hypertension, smoking, and diabetes are the key elements in primary prevention of stroke in eastern Europe, where stroke mortality remains high.
Key Words: mortality prospective studies risk factors Lithuania
| Introduction |
|---|
|
|
|---|
| Subjects and Methods |
|---|
|
|
|---|
Almost one third of all randomly selected men refused to take part in the initial screening. A participant/nonparticipant substudy was performed in Kaunas to reveal possible differences between participants and nonparticipants in the risk factor screening. This substudy showed that there was no significant difference between participants and nonparticipants in mean levels of the main risk factors, although both systolic and diastolic BPs, glucose level, and prevalence of smokers tended to be higher in the nonparticipant than in the participant group.11
The methods used in the risk factor survey have been described in
detail previously.11 Briefly, Hawksley random zero
sphygmomanometers were used for BP measurements. BP was measured from
the right arm of the subject after 5 minutes' rest in a sitting
position. The fifth phase of Korotkoff sounds was recorded as
diastolic BP. The mean of two BP readings was used. We
considered a person to have an elevated BP if systolic BP was
160 mm Hg or diastolic BP was
95 mm Hg or if the person
had taken antihypertensive drugs within the previous 2 weeks. Weight
was measured with a balance scale with subjects wearing light clothing
and no shoes. Height was measured to the nearest centimeter, with
subjects not wearing shoes. BMI, ie, weight (in kilograms) divided by
height (in meters) squared, was used as a measure of relative body
weight. Glucose tolerance was examined 1 hour after a 75-g glucose
load. Participants with a history of diabetes mellitus were excluded
from the glucose tolerance test. A 1-hour postload blood glucose level
between 10.08 and 19.5 mmol/L was considered impaired glucose
tolerance; a glucose level of 19.6 mmol/L or more was considered
diabetes mellitus. Men who met this criterion of diabetes and those
with a previous history of diabetes mellitus were considered diabetic
in the present study. Serum total cholesterol was
determined by use of the heparin-manganate precipitation method
(Liebermann-Burchard). All serum samples were analyzed in the
same laboratory. Information about smoking habits was obtained by use
of a standard set of questions. Respondents were classified as smokers
(men who smoked regularly for at least 1 year more than once a day, on
average, and had smoked during the preceding 6 months) or nonsmokers
(men who had never smoked and men who had smoked previously but stopped
smoking 6 months or more before the survey). Self-reported
information about previous history of stroke and myocardial infarction
was also obtained on the questionnaire and was verified from medical
records afterward.
The end point used in the present study was death from stroke. Mortality data were collected continually during the 20-year follow-up. The list of participants was checked monthly against mortality registration that covered the entire population of Kaunas. Throughout the follow-up period, the eighth revision of the ICD was used. All deaths that listed ICD codes 430 through 438 as the underlying cause of death were reviewed and checked against all available medical information (records in outpatient departments and hospitals, autopsy reports, and medicolegal reports) and were considered stroke in the present analyses. There were 75 stroke deaths (9.2% of all deaths) during the 20-year follow-up and 742 deaths from other causes: 249 (30.5%) from neoplasms, 369 (45.2%) from all cardiovascular disease, 230 (28.2%) from ischemic heart disease, 83 (10.2%) from external causes, and 116 (14.2%) from other causes. The 211 men who were lost to follow-up did not differ significantly from the remaining group with respect to cardiovascular risk factors, prevalent hypertension, diabetes, or smoking.
Statistical Analyses
Estimates of RR and 95% CIs were based on the Cox proportional
hazards model.12 The Cox proportional hazards model was
also used to produce predicted survival curves and the survival
function estimates and to compare different survival curves. In cases
of uncensored observations, each subject was followed up until December
31, 1994, or until death from another cause, whichever came first. The
average follow-up time was 17.5 years. All analyses were
done with adjustment for age. The population-attributable risk was
calculated according to the method of Breart and Padieu.13
Statistical analyses were performed with SAS (Statistical
Analysis Systems) statistical software in a VAX computer at the
National Public Health Institute in Helsinki, Finland.
| Results |
|---|
|
|
|---|
|
Results from the univariate and
multivariate analyses are shown in Table 2
. In the univariate analysis,
diabetes was associated with a 5-fold increase in the risk of death
from stroke (95% CI, 1.6 to 16.8; P=.005), hypertension was
associated with a 2.4-fold increase in risk (95% CI, 1.5 to 3.7;
P=.0002), and smoking was associated with a 1.8-fold
increase in risk (95% CI, 1.2 to 2.9; P=.01). In
addition, both systolic (P=.0001) and
diastolic (P=.0006) BPs were strongly
associated with the risk of death from stroke. Serum total
cholesterol level, impaired glucose tolerance, and BMI were
not significant risk factors.
|
To investigate whether some of the risk factors were independently
associated with the risk of death from stroke,
multivariate analysis was used (Table 2
). Age
(RR=1.11; P=.0001), systolic BP (RR=1.02;
P=.0001), diabetes (RR=4.17; P=.02), and smoking
(RR=2.01; P=.004) were found to be independent risk factors
for death from stroke. The population-attributable risks of stroke
related to hypertension, smoking status, diabetes, and glucose
intolerance were 24.9%, 19.2%, 3.1%, and 4.9%, respectively.
Predicted survival curves estimated by the Cox proportional hazards
model for nondiabetic versus diabetic men, nonsmokers versus smokers,
and normotensive versus hypertensive men are shown in the
Figure
. After only
2 years of follow-up, the
survival curve for diabetic men began to separate from the curve for
nondiabetic men (Figure
, panel A). Survival curves for nonsmokers and
for normotensives began to separate from survival curves for smokers
and for hypertensive men after about 3 and 4 years' follow-up,
respectively (Figure
, panels B and C). After adjustment for age,
survival was significantly better in nondiabetic, nonsmoking, and
normotensive men than in those who were diabetic (P=.02),
smoked cigarettes (P=.004), or were hypertensive
(P=.0001).
|
| Discussion |
|---|
|
|
|---|
Hypertension is the best-known risk factor for stroke. Hence, our findings are in accord with a large number of previous studies.8 9 14 15 It has been shown that the risk of stroke in hypertensive subjects can be effectively reduced by lowering BP levels with antihypertensive drugs.16 17 Our data stress the importance of primary prevention and more efficient hypertension control in Lithuania. The comparative data from the WHO MONICA project also show that BP levels in Kaunas are relatively high and that antihypertensive drug treatment is not very efficient.18 Furthermore, a statistically significant increase in mean level of BP among both men and women aged 35 to 64 years has been observed during the period from 1987 to 1993 in Kaunas.19 In addition, only one of every five men with elevated BP had been informed of his condition, and only one fourth of those subjects who were aware of their hypertension were receiving proper treatment.19 The population-attributable risk estimates indicate that it would be possible to prevent every fourth stroke death among men in Kaunas if the BPs of hypertensive men were normalized.
Several investigators have found diabetes to be an independent risk factor for stroke,14 19 20 21 22 23 24 25 26 but in some studies, diabetes did not remain an independent risk factor in multivariate analysis.27 28 Some recent studies have suggested that diabetes might be associated with the risk of ischemic stroke but not hemorrhagic stroke.23 24 29 Unfortunately, during the first half of the present study, no attempts were made to verify diagnosis of stroke subtype, and therefore we could not evaluate the effect of diabetes (or other risk factors) on ischemic and hemorrhagic stroke separately.
Impaired glucose tolerance appeared not to be associated with stroke mortality in the present study. This is in the conflict with the recent results from the Honolulu Heart Program20 23 and the Whitehall study,30 in which glucose intolerance was shown to be an independent risk factor for stroke. In the present study, the postload glucose concentration was measured 1 hour after a 75-g glucose load only. It is therefore possible that some healthy persons were misclassified as having impaired glucose tolerance. Nevertheless, a similar 1-hour glucose tolerance test was also used in the Honolulu Heart Program.
The risk of diabetes and its complications vary among populations, and much of this variation is due to obesity. The population of Kaunas is one of the most obese in Europe, as seen from the mean BMI values in the present study and from the comparative data of the WHO MONICA project.18 Although BMI seems not to be an independent risk factor for stroke,15 it is important because of its associations with other risk factors, such as systolic and diastolic BPs, serum cholesterol level, and plasma glucose level.31 Some studies have demonstrated the importance of a central pattern of body fat distribution in predicting coronary heart disease after adjustment for BMI.32 33 It was suggested that the intra-abdominal tissue has a highly sensitive lipomobilization capacity that results in high portal free fatty acid concentrations, which in turn generate, through hepatic regulation, elevated risk factor levels for cardiovascular disease.34 In other words, prevention and control of obesity is certainly one of the main issues in the prevention of cardiovascular diseases, hypertension, and diabetes and thereby indirectly in the prevention of stroke.
Although previously debated, it is now commonly agreed that smoking is an independent risk factor for stroke.35 36 In Kaunas, almost 20% of all stroke deaths in men could be attributed to smoking. Wider and more intensive public health policy and education about the harmful effects of smoking are needed in Lithuania. Prevention of smoking could help to prevent almost one fifth of stroke deaths in middle-aged men and obviously a large number of cases of coronary heart disease, lung cancer, and other chronic diseases.
We did not find serum total cholesterol level to be a significant risk factor for mortality in univariate analysis. The association between cholesterol and stroke seems to differ by the type of stroke, ie, a low serum total cholesterol level is associated with hemorrhagic stroke, whereas a high cholesterol level is associated with ischemic stroke.9 37 A recent overview of 10 prospective studies of the association between serum cholesterol concentrations >5.7 mmol/L and stroke risk found the pooled risk to be 1.31, which was statistically significant.38 Findings from the Honolulu Heart Program10 suggested that the association between serum total cholesterol level and increased risk for thromboembolic stroke sometimes may be underestimated, in part because of shared or competing risk with coronary heart disease, the clinical manifestation of atherosclerosis that generally occurs earlier in life and with greater frequency than thromboembolic stroke.
In conclusion, our findings confirmed that BP, diabetes, and daily cigarette smoking were the main risk factors for death from stroke in the middle-aged, male Kaunas population. Both BP and smoking are modifiable risk factors for stroke, and the means for effective treatment of diabetes also exists. Since about half of stroke deaths can be attributed to these three risk factors, urgent measures aimed at changes of lifestyle are required in Lithuania, where increasing trends in incidence and mortality of stroke have been observed.
| Selected Abbreviations and Acronyms |
|---|
|
Received September 29, 1995; revision received November 27, 1995; accepted January 15, 1996.
| References |
|---|
|
|
|---|
2.
Thom TJ. Heart disease, cancer, and stroke
mortality trends and their interrelations: an international
perspective. Circulation. 1994;90:574-582.
3. Miseviciene I. Epidemiology of Main Noncommunicable Diseases and Some Issues of Methodology of Primary Prevention in Lithuania [in Russian]. Kaunas, Lithuania: Kaunas Medical Institute; 1990. Dissertation.
4. Rastenyte D, Tuomilehto J, Sarti C, Cepaitis Z, Bluzhas J. Trends in incidence and mortality of stroke in Kaunas, Lithuania, 1986-1993. Cerebrovasc Dis. 1996;6:13-21.
5. Stegmayr B, Harmsen P, Rajakangas A-M, Rastenyte D, Sarti C, Thorvaldsen P, Tuomilehto J. Stroke around the Baltic Sea: incidence, case fatality and population risk factors in Denmark, Finland, Sweden and Lithuania. Cerebrovasc Dis. 1996;6:80-88.
6. Stokes J III, Kannel WB, Wolf PA, Cupples A, D'Agostino RB. The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years' follow-up in the Framingham study. Circulation. 1987;75(suppl V):V-65-V-73.
7.
Selmer R. Blood pressure and twenty-year
mortality in the city of Bergen, Norway. Am J
Epidemiol. 1992;136:428-440.
8.
Menotti A, Lanti M, Seccareccia F, Giampoli S, Dima
F. Multivariate prediction of the first major
cerebrovascular event in an Italian population sample of
middle-aged men followed up for 25 years.
Stroke. 1993;24:42-48.
9. Neaton JD, Wentworth DN, Cutler J, Stamler J, Kuller L. Risk factors for death from different types of stroke. Ann Epidemiol. 1993;3:493-499. [Medline] [Order article via Infotrieve]
10. Benfante R, Yano K, Hwang L-J, Curb D, Kagan A, Ross W. Elevated serum cholesterol is a risk factor for both coronary heart disease and thromboembolic stroke in Hawaiian Japanese men: implications of shared risk. Stroke. 1994;25:814-820. [Abstract]
11. Glasunov IS, Dowd JE, Baubiniene A, Grabauskas V, Sturmans F, Schuurman JH, eds. The Kaunas-Rotterdam Intervention Study. Amsterdam, Netherlands: Elsevier/North Holland Biomedical Press; 1981.
12. Cox DR. Regression models and life tables. J R Stat Soc. 1972;34:187-220.
13. Breart G, Padieu R. Méthodes en épidémiologie. 3rd ed. Paris, France: Flammarion. Médecine Sciences; 1985.
14.
Tuomilehto J, Bonita R, Stewart A, Nissinen A, Salonen
JT. Hypertension, cigarette smoking, and the decline in stroke
incidence in eastern Finland. Stroke. 1991;22:7-11.
15.
Ellekjaer EF, Wyller TB, Scerre JM, Holmen J.
Lifestyle factors and risk of cerebral infarction.
Stroke. 1992;23:829-834.
16. Tuomilehto J, Nissinen A, Wolf E, Geboers J, Piha T, Puska P. Effectiveness of treatment with antihypertensive drugs and trends in mortality from stroke in the community. Br Med J. 1985;291:857-861.
17. Salomaa V, Tuomilehto J, Nissinen A, Korhonen HJ, Vartiainen E, Kartovaara L, Puska P. Development of hypertension care in Finland in 1982-87. J Hypertens. 1989;7:837-844. [Medline] [Order article via Infotrieve]
18. Pajak A, Kuulasmaa K, Tuomilehto J, Ruokokoski E, on behalf of the WHO MONICA Project. The WHO MONICA project: geographical variation in the major risk factors of coronary heart disease in men and women aged 35-64 years. World Health Stat Q. 1988;41:115-140. [Medline] [Order article via Infotrieve]
19. Rastenyte D, Domarkiene S. Mortality from intracerebral hemorrhage and arterial hypertension in the Kaunas population [in Lithuanian with English abstract]. Medicina. 1995;31(suppl 2):485-489.
20.
Abbott RD, Donahue RP, MacMahon SW, Reed DM, Yano
K. Diabetes and the risk of stroke: the Honolulu Heart
Program. JAMA. 1987;257:949-952.
21.
Barrett-Connor E, Khaw KT. Diabetes mellitus: an
independent risk factor for stroke? Am J Epidemiol. 1988;128:116-123.
22. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993;16:434-444. [Abstract]
23. Burchfield CM, Curb DJ, Rodriguez BL, Abbott RD, Chiu D, Yano K. Glucose intolerance and 22-year stroke incidence: the Honolulu Heart Program. Stroke. 1994;25:951-957. [Abstract]
24. Jamrozik K, Broaghurst J, Anderson CS, Stewart-Wynne EG. The role of lifestyle factors in the etiology of stroke: a population-based case-control study in Perth, western Australia. Stroke. 1994;25:51-59. [Abstract]
25. Stegmayr B, Asplund K. Diabetes as a risk factor for stroke: a population perspective. Diabetologia. 1995;38:1061-1068. [Medline] [Order article via Infotrieve]
26.
Tuomilehto J, Rastenyte D, Jousilahti P, Sarti C,
Vartiainen E. Diabetes mellitus as a risk factor for stroke:
prospective study of the middle-aged Finnish population.
Stroke. 1996;27:210-215.
27. Welin L, Swärdsudd K, Wilhelmsen L, Larsson B, Tibblin G. Analysis of risk factors for stroke in a cohort of men born in 1913. N Engl J Med. 1987;317:521-526. [Abstract]
28.
Herman B, Schitz PIM, Leyten ACM, van Luijik JH, Freken
CWGM, Op de Coul AAW, Schulte BPM. Multivariate
logistic analysis of risk factors for stroke in Tilburg, the
Netherlands. Am J Epidemiol. 1983;118:514-525.
29. Carieri PB, Orefice G, Maiorino A, Provitera V, Balzano G, Lucarielo A. Age-related risk factors for ischemic stroke in Italian men. Neuroepidemiology. 1994;13:28-33. [Medline] [Order article via Infotrieve]
30. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. Br Med J. 1983;287:867-870.
31.
DiPietro L, Ostfeld AM, Rosner GL. Adiposity and
stroke among older adults of low socioeconomic status: the Chicago
stroke study. Am J Public Health. 1994;84:14-19.
32. Kannel WB, Cupples LA, Ramaswami R, Strokes J, Kreger BE, Higgins M. Regional obesity and risk of cardiovascular disease: the Framingham study. J Clin Epidemiol. 1991;44:183-190. [Medline] [Order article via Infotrieve]
33.
Larsson B, Bengtsson C, Bjorntorp P, Lapidus L,
Sjostrom L, Svardsudd K, Tibblin G, Wedel H, Welin L, Wilhelmsen
L. Is abdominal body fat distribution a major explanation for
the sex difference in the incidence of myocardial infarction? The study
of men born in 1913 and the study of women, Göteborg,
Sweden. Am J Epidemiol. 1992;135:266-273.
34.
Björntorp P. `Portal' adipose tissue as
a generator of risk factors for cardiovascular disease
and diabetes. Arteriosclerosis. 1990;10:493-496.
35. Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. Br Med J. 1989;298:789-794.
36. Bonita R, Beaglehole R. Smoking, drinking, and the risk of stroke. Cardiovasc Risk Factors. 1993;3:201-206.
37. Gatchev O, Rastam L, Lindberg G, Gullberg B, Eklund GA, Isacsson SO. Subarachnoid hemorrhage, cerebral hemorrhage and serum cholesterol concentration in men and women. Ann Epidemiol. 1993;3:403-409. [Medline] [Order article via Infotrieve]
38. Quiziblash N, Duffy SW, Warlow C, Mann J. Lipids are risk factors for ischemic stroke: overview and review. Cerebrovasc Dis. 1992;2:127-136.
This article has been cited by other articles:
![]() |
M. Hyvarinen, Q. Qiao, J. Tuomilehto, T. Laatikainen, R. J. Heine, C. D.A. Stehouwer, K. G. M.M. Alberti, K. Pyorala, B. Zethelius, B. Stegmayr, et al. Hyperglycemia and Stroke Mortality: Comparison between fasting and 2-h glucose criteria Diabetes Care, February 1, 2009; 32(2): 348 - 354. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Everett, T. Kurth, J. E. Buring, and P. M. Ridker The Relative Strength of C-Reactive Protein and Lipid Levels as Determinants of Ischemic Stroke Compared With Coronary Heart Disease in Women J. Am. Coll. Cardiol., December 5, 2006; 48(11): 2235 - 2242. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Harmsen, G. Lappas, A. Rosengren, and L. Wilhelmsen Long-Term Risk Factors for Stroke: Twenty-Eight Years of Follow-Up of 7457 Middle-Aged Men in Goteborg, Sweden Stroke, July 1, 2006; 37(7): 1663 - 1667. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-F. Zhang, J. Attia, C. D'Este, and X.-H. Yu Prevalence and Magnitude of Classical Risk Factors for Stroke in a Cohort of 5092 Chinese Steelworkers Over 13.5 Years of Follow-up Stroke, May 1, 2004; 35(5): 1052 - 1056. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Shahar, L. E. Chambless, W. D. Rosamond, L. L. Boland, C. M. Ballantyne, P. G. McGovern, and A. R. Sharrett Plasma Lipid Profile and Incident Ischemic Stroke: The Atherosclerosis Risk in Communities (ARIC) Study Stroke, March 1, 2003; 34(3): 623 - 631. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Eigenbrodt, K. M. Rose, D. J. Couper, D. K. Arnett, R. Smith, and D. Jones Orthostatic Hypotension as a Risk Factor for Stroke : The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1996 Stroke, October 1, 2000; 31(10): 2307 - 2313. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Hart, D. J. Hole, and G. D. Smith Comparison of Risk Factors for Stroke Incidence and Stroke Mortality in 20 Years of Follow-Up in Men and Women in the Renfrew/Paisley Study in Scotland Stroke, August 1, 2000; 31(8): 1893 - 1896. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J Milionis, A. F Winder, and D. P Mikhailidis Lipoprotein (a) and stroke J. Clin. Pathol., July 1, 2000; 53(7): 487 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Vauthey, G. R. de Freitas, G. van Melle, G. Devuyst, and J. Bogousslavsky Better outcome after stroke with higher serum cholesterol levels Neurology, May 23, 2000; 54(10): 1944 - 1949. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Hart, D. J. Hole, and G. D. Smith Risk Factors and 20-Year Stroke Mortality in Men and Women in the Renfrew/Paisley Study in Scotland Stroke, October 1, 1999; 30(10): 1999 - 2007. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Guerrero-Romero and M. Rodriguez-Moran Proteinuria Is an Independent Risk Factor for Ischemic Stroke in Non–Insulin-Dependent Diabetes Mellitus Stroke, September 1, 1999; 30(9): 1787 - 1791. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A Papadakis, D. P Mikhailidis, and A. F Winder Lipids and stroke: neglect of a useful preventive measure? Cardiovasc Res, November 1, 1998; 40(2): 265 - 271. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Tanne, S. Yaari, and U. Goldbourt Risk Profile and Prediction of Long-Term Ischemic Stroke Mortality : A 21-Year Follow-up in the Israeli Ischemic Heart Disease (IIHD) Project Circulation, October 6, 1998; 98(14): 1365 - 1371. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. X. You, J. J. McNeil, H. M. O'Malley, S. M. Davis, A. G. Thrift, and G. A. Donnan Risk Factors for Stroke Due to Cerebral Infarction in Young Adults Stroke, October 1, 1997; 28(10): 1913 - 1918. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |